Predictive factors for sustained virological response after treatment with pegylated interferon α-2a and ribavirin in patients infected with HCV genotypes 2 and 3.

2014

Background Previous trials have often defined genotype 2 and 3 patients as an “easy to treat” group and guidelines recommend similar management.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

52

References

9

Citations